Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Succinylcholine chloride (substance) |
Is a |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Allergy to succinylcholine |
Causative agent |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
isuccinylcholinklorid 100 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Brevidil 124mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Suxamethonium bromide 124mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Product containing succinylcholine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Succinylcholine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Succinylcholine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Suxamethonium chloride 100mg/2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
succinylcholinklorid 20 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
succinylcholinklorid 1000 mg/10 ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
succinylcholinklorid 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
succinylcholinklorid 50 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
succinylcholinklorid 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
suxamethoniumchlorid 100 mg/2 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Product containing precisely succinylcholine 124 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Suxamethonium adverse reaction (disorder) |
Causative agent |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
følsomhed over for suxamethonium |
Causative agent |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Allergy to succinylcholine |
Causative agent |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely succinylcholine 124 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely succinylcholine 124 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Succinylcholine chloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
|
Product containing precisely succinylcholine 124 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Product containing only succinylcholine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Product containing only succinylcholine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Product containing only succinylcholine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |
Suxamethonium apnea |
Causative agent |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
2 |
Hypersensitivity to succinylcholine (finding) |
Causative agent |
True |
Succinylcholine (substance) |
Inferred relationship |
Some |
1 |